ClinicalTrials.Veeva

Menu

Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT

K

King's College London

Status

Suspended

Conditions

Carotid Atherosclerosis

Treatments

Other: PET-CT with CuATSM

Study type

Observational

Funder types

Other

Identifiers

NCT01000181
EudraCT 2009-011476-30
GSTT Charity 251983
KCLADS09/1

Details and patient eligibility

About

The build up of plaque in the wall of the artery supplying blood to the brain poses a risk of stroke when the plaques become unstable and fragile. It is important to determine which patients are most at risk so that surgery can be performed. There is evidence that the risk is greatest when these plaques become oxygen deficient (hypoxic). The investigators wish to use PET imaging to identify hypoxic plaque, to help decide whether and when to perform surgery. The investigators have developed radiotracers (imaging agents) for this purpose, and this study is to determine whether they will work in patients.

Enrollment

10 estimated patients

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male/Female patients who are 55yrs or older and for whom carotid endarterectomy is clinically indicated and a decision has been made to perform a carotid endarterectomy.
  • Normal liver and adequate renal function. Assessed by measuring eGFR (>50ml/min) and creatinine (<130μmol/L)
  • Life expectancy > 12 weeks
  • Patients should be able to tolerate head/neck mask as well as lying in the PET-CT scanner

Exclusion criteria

  • Abnormal liver and renal function (eGFR <50ml/min, Creatinine >130μmol/L)
  • Patient unwilling to provide written informed consent

Trial design

10 participants in 1 patient group

Patients undergoing carotid endarterectomy
Treatment:
Other: PET-CT with CuATSM

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems